Seeking Alpha

Arena Pharmaceuticals (ARNA) +8.7% premarket after announcing its weight-loss drug candidate...

Arena Pharmaceuticals (ARNA) +8.7% premarket after announcing its weight-loss drug candidate lorcaserin was accepted for review by European regulators and confirming that an FDA advisory committee will meet during Q2 to discuss ARNA’s resubmitted application for lorcaserin.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs